CLOROX CO DE
For the period ended Mar 31, 2025. Filed May 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 5, 2025
CLX$106.60+1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets
| 3/31/2025 | 6/30/2024 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $226 | $202 |
| Receivables, net | 597 | 695 |
| Inventories, net | 635 | 637 |
| Prepaid expenses and other current assets | 132 | 88 |
| Total current assets | 1,590 | 1,622 |
| Property, plant and equipment, net of accumulated depreciation and amortization of $2,872 and $2,821, respectively | 1,245 | 1,315 |
| Operating lease right-of-use assets | 349 | 360 |
| Goodwill | 1,222 | 1,228 |
| Trademarks, net | 501 | 538 |
| Other intangible assets, net | 68 | 143 |
| Other assets | 537 | 545 |
| Total assets | $5,512 | $5,751 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Notes and loans payable | $54 | $4 |
| Current operating lease liabilities | 85 | 84 |
| Accounts payable and accrued liabilities | 2,016 | 1,486 |
| Total current liabilities | 2,155 | 1,574 |
| Long-term debt | 2,483 | 2,481 |
| Long-term operating lease liabilities | 322 | 334 |
| Other liabilities | 341 | 848 |
| Deferred income taxes | 21 | 22 |
| Total liabilities | 5,322 | 5,259 |
| Commitments and contingencies | ||
| Stockholders’ equity | ||
| Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding | — | — |
| Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2025 and June 30, 2024; and 123,251,595 and 124,201,807 shares outstanding as of March 31, 2025 and June 30, 2024, respectively | 131 | 131 |
| Additional paid-in capital | 1,304 | 1,288 |
| Retained earnings | 99 | 250 |
| Treasury stock, at cost: 7,489,866 and 6,539,654 shares as of March 31, 2025 and June 30, 2024, respectively | (1,331) | (1,186) |
| Accumulated other comprehensive net (loss) income | (176) | (155) |
| Total Clorox stockholders’ equity | 27 | 328 |
| Noncontrolling interests | 163 | 164 |
| Total stockholders’ equity | 190 | 492 |
| Total liabilities and stockholders’ equity | $5,512 | $5,751 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.